|
- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
回复 tim889 的帖子
"乙肝疫苗是默克出于人道主义几乎是送给中国的" - 更多细节:
https://globalcenters.columbia.e ... nternational-health
1989年，瓦格洛斯博士在担任默克公司董事长兼首席执行官时，决定以700万美元的价格向中国出售生产乙肝疫苗的技术，旨在帮助中国对抗其对公众的最大威胁。 健康。 在这个项目中，默克公司没有从销售中获得任何利润或特许权使用费。
据《上海日报》报道，20 世纪 80 年代，中国每年报告约 1.2 亿乙肝携带者，10% 的新生儿从母亲那里感染慢性乙肝。
后来，两座工厂由当地的科学家和工程师在 1993 年在北京和另一座于 1994 年在深圳建成，这些工厂是在 1993 年在北京建造的，另一座是在深圳。他们现在每年生产超过 2000 万剂。
以这种供应为后盾，中国卫生部于 2002 年将乙肝疫苗接种纳入其全国扩大免疫计划。2006 年的官方研究表明，婴儿乙肝携带者已从 1992 年的 9.7% 减少到 2006 年的不到 1%。 迄今为止，已有数亿婴儿接种了乙肝疫苗。
In 1989, when Dr. Vagelos served as the chairman and CEO of Merck & Co. he made a decision to sell the technology of producing the hepatitis B vaccine to China for $7 million, aiming to help the country fight against its biggest threat to public health. In this project, Merck received no profits or royalties from the sale.
According to Shanghai Daily, in the 1980s, around 120 million carriers of hepatitis B were reported every year in China and 10 percent of newborns acquired chronic hepatitis B from their mothers.
Later on, two plants using local scientists and engineers who had learned from and worked with MSD were built, one in Beijing in 1993 and the other in Shenzhen in 1994. Together they now produce more than 20 million doses per year.
Back by that kind of supply, China's Ministry of Health integrated the hepatitis B vaccination into its nationwide EPI program in 2002. Official research in 2006 shows that infant hepatitis B carriers have been reduced from 9.7 percent in 1992 to less than 1 percent in 2006. Till now, hundreds of millions of infant have received hepatitis B vaccine.
[当然，HBV疫苗的主要成分是HBsAg。 所以生产安全疫苗的技术是非常非常重要]
|
|
楼主: tim889
发表于 2022-12-15 10:34
